Meth vaccine shows promising results in early tests
Scripps Research Institute Associate Professor Michael Taffe, Research Associate Michelle Miller, and colleagues have developed a promising vaccine against a methamphetamine high.
Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of meth intoxication. If the vaccine proves effective in humans too, it could become the first specific treatment for meth addiction, which is estimated to affect 25 million people worldwide.
"This is an early-stage study, but its results are comparable to those for other drug vaccines that have then gone to clinical trials," said Michael A. Taffe, an associate professor in TSRI's addiction science group, known as the Committee on the Neurobiology of Addictive Disorders. Taffe is the senior author of the study, which is currently in press with the journal Biological Psychiatry.
A Common and Dangerous Drug of Abuse
Over the past two decades, methamphetamine has become one of the most common drugs of abuse around the world. In the United States alone there are said to be more than 400,000 current users, and in some states, including California, meth accounts for more primary drug abuse treatment admissions than any other drug. Meth has characteristics that make it more addictive than other common drugs of abuse, and partly for this reason, there are no approved treatments for meth addiction.
In recent years, scientists at TSRI and other institutions have taken the innovative approach of developing vaccines against addictive drugs. These vaccines evoke antibody responses against drug molecules, just as traditional vaccines evoke antibody responses against viruses or bacteria. Anti-drug antibodies are meant to grab hold of drug molecules and keep them from getting into the brain—preventing the drug from giving the user a high and removing the incentive for taking the drug.
Vaccines against nicotine and cocaine are already in clinical trials. Some meth vaccines have been tested in animals, but generally with unpromising results. The methamphetamine molecule is structurally simple, making it relatively unnoticeable to the immune system. Meth and its main metabolite, ordinary amphetamine, also tend to linger once they get into the nervous system, so that even a little drug goes a long way. "The simple structure and long half-life of this drug make it a particularly difficult vaccine target," said Kim Janda, the Ely R. Callaway, Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at TSRI.
Two years ago Janda and his laboratory developed six candidate meth vaccines. In each, the main active ingredient was a chemical cognate of the methamphetamine molecule—that otherwise would be too small to evoke any antibody response—linked to a larger, antibody-provoking carrier molecule. Early tests in mice indicated that three of these vaccine candidates could evoke a strong antibody response to meth. Taffe's laboratory later tested these three vaccines in rats and found the one, designated MH6, that worked best at blocking two typical effects of meth—an increase in physical activity and a loss of the usual ability to regulate body temperature.
In the new study, members of Taffe's laboratory, including Research Associate Michelle L. Miller, who was lead author of the study, investigated the MH6 vaccine in more depth. Using a different experimental setup, they found again that it prevented a rise in body temperature and burst of wheel-running hyperactivity that otherwise occur after meth exposure. Underlying these promising effects on behavioral measures was a robust antibody response, which in vaccinated rats kept more of the drug in the bloodstream and out of the nervous system, compared to control rats. "These are encouraging results that we'd like to follow up with further animal tests, and, we hope, with clinical tests in humans some day," said Miller.
"I think that this vaccine has all the right features to allow it to move forward in development," said Janda. "It certainly works better than the other active vaccines for meth that have been reported so far."
The Next Big Challenge
A separate group of researchers has reported promising animal test results for an antibody-based treatment. In this approach, the anti-meth antibodies are grown in cultured cells using standard biotechnology methods and then injected into the animal in a concentrated dose, preventing a meth high. Antibody-based therapies are commonly used to treat cancer and chronic immunological conditions. But they are typically expensive, costing thousands of dollars per dose, and the effects of a dose last for a few weeks at most. A meth treatment probably would have to be much more cost-effective to be widely useful, as addicts frequently have little money and no health insurance and receive their treatments from government health services.
In principle, an active vaccine would be cheap to make and administer and would confer protection for months per dose, rather than weeks with conventional monoclonal antibody therapy. In practice, active meth vaccine candidates don't yet last that long; for example, the MH6 candidate in the current study was given in four doses over 12 weeks. But Janda and Taffe believe that with further adjustment, an active meth vaccine could sustain an anti-meth antibody response for a much longer period.
"Extending the duration of protection is the next big scientific challenge in this field," said Taffe.
More information: "A Methamphetamine Vaccine Attenuates Methamphetamine-Induced Disruptions in Thermoregulation and Activity in Rats," www.biologicalpsyc… 3-7/abstract
Journal reference: Biological Psychiatry
Provided by Scripps Research Institute
- Toward a vaccine for methamphetamine abuse May 11, 2011 | not rated yet | 0
- Meds can help recovering meth addicts stay sober Jun 14, 2012 | not rated yet | 0
- Scientists create vaccine against heroin high Jul 20, 2011 | not rated yet | 0
- Methamphetamine use increasing again, researchers find Jan 25, 2012 | not rated yet | 0
- DEA demonstrates how to make meth May 29, 2007 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
Psychology & Psychiatry 3 hours ago | not rated yet | 0 |
A Mediterranean diet with added extra virgin olive oil or mixed nuts seems to improve the brain power of older people better than advising them to follow a low-fat diet, indicates research published online in the Journal of ...
Psychology & Psychiatry 13 hours ago | 2 / 5 (1) | 2
More people are being diagnosed with eating disorders every year and the most common type is not either of the two most well known—bulimia or anorexia—but eating disorders not otherwise specified (eating disorders that ...
Psychology & Psychiatry 13 hours ago | not rated yet | 0
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
Psychology & Psychiatry 14 hours ago | 3.3 / 5 (10) | 0 |
(Medical Xpress)—Individuals who learn two languages at an early age seem to switch back and forth between separate "sound systems" for each language, according to new research conducted at the University of Arizona.
Psychology & Psychiatry 15 hours ago | 5 / 5 (4) | 0 |
(HealthDay)—Injections of a sugar solution appear to help relieve knee pain and stiffness related to osteoarthritis, a new study suggests.
24 minutes ago | not rated yet | 0 |
(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...
32 minutes ago | not rated yet | 0 |
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
27 minutes ago | not rated yet | 0 |
(HealthDay)—Obese and overweight men and women who suffer from heartburn often report relief when they lose weight, a new study shows.
14 minutes ago | not rated yet | 0 |
(HealthDay)—When it comes to the care of your children's teeth, dentists aren't the only experts who can help.
34 minutes ago | not rated yet | 0
(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), prolonged prone positioning during mechanical ventilation is associated with significantly reduced mortality at 28 and 90 days, ...
54 minutes ago | not rated yet | 0